The global viscosupplementation market is anticipated to expand at a moderate CAGR of 5.7% during the forecast period. The industry is likely to cross a valuation of US$ 3,777.4 million by 2034.
Due to an expanding senior population, the viscosupplementation treatment industry is anticipated to accelerate progressively from 2024 to 2034. As a result, the sales of viscosupplementation are estimated to reach US$ 2,167.3 million in 2024.
Rising demand for non-surgical osteoarthritis treatments, the prevalence of lifestyle-related illnesses, and advances in the development of hyaluronic acid-based therapies are all projected to strengthen the market.
Emerging Patterns in the Viscosupplementation Market
| Attributes | Details |
|---|---|
| Market Value for 2024 | US$ 2,167.3 million |
| Market Value for 2034 | US$ 3,777.4 million |
| Market CAGR from 2024 to 2034 | 5.7% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The industry is undergoing a substantial change due to an aging population. As people age, their risk of developing osteoarthritis rises, increasing the demand for effective treatments.
Viscosupplementation emerges as a feasible option, providing a non-surgical way to control joint discomfort and enhance mobility in elderly individuals. The growing aging demographic serves as a primary driver for the market expansion of viscosupplementation, with healthcare professionals increasingly focused on addressing the special needs of this age segment.
Continuous technological improvements substantially impact the evolution of viscosupplementation, improving its efficacy and patient comfort. Innovations in viscosupplement formulation, delivery techniques, and overall performance lead to increased viscosity, durability, and effectiveness throughout time.
The advances in technology make the treatment more appealing to patients and attract healthcare practitioners who want cutting-edge solutions for their patients. The viscosupplementation market thrives on technological advancement, with constant research and development efforts boosting innovation and ensuring that viscosupplementation remains a cutting-edge choice in the treatment of osteoarthritis.
Principal Consultant
Viscosupplementation's attraction is heightened by its correlation with fewer side effects and a shorter recovery time than surgical procedures. Patients are generally drawn to treatments that provide excellent relief, pose fewer hazards, and require shorter recovery times.
This choice improves the market by establishing viscosupplementation as an appealing option for people looking for a balance of efficacy and minimal disruption in their daily lives. The emphasis on patient safety and convenience helps the viscosupplementation market expansion, as viscosupplementation becomes a popular alternative for individuals preferring a faster and smoother recovery experience.
Regulations impose significant obstacles on the viscosupplementation market. Health authorities' stringent regulatory procedures for approving viscosupplements can stifle market expansion of viscosupplementation.
Complex and long approval processes deter firms from releasing new items or limit their capacity to respond rapidly to viscosupplementation demands. Regulatory uncertainty and developing standards are expected to present vendor challenges, resulting in product launch delays and increased compliance costs.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Short-term Analysis (From 2019 to 2023):
The viscosupplementation equipment market grew steadily, driven by increasing awareness, aging demographics, and rising orthopedic diseases. Product formulation innovations and expanding uses helped to sustain the market's favorable trend.
| Attributes | Details |
|---|---|
| Market CAGR from 2019 to 2023 | 4.4% |
Mid-term Analysis (From 2024 to 2029):
Advancements in medical technology, combined with an increasing emphasis on less invasive therapies, are projected to propel the viscosupplementation industry. Increased collaboration among viscosupplementation vendors and healthcare providers is anticipated to be critical to viscosupplementation market growth.
Long-term Analysis (From 2029 to 2034):
Due to ongoing research and development, the viscosupplementation equipment market is expected to increase steadily by 2034. Evolving reimbursement regulations and a better awareness of the benefits of viscosupplements are likely to help the market grow in the long run.
Future Market Insights (FMI) has analyzed orthobiologics and cartilage repair markets. The figures show the predicted market expansion of viscosupplementation from 2024 to 2034 compared to other markets. It offers the opportunity for earnings in the adjacent markets listed below.
Viscosupplementation Market:
| Attributes | Viscosupplementation Industry |
|---|---|
| Value-based CAGR (2024 to 2034) | 5.7% |
| Growth Factor | The viscosupplementation treatment market is expanding due to rising demand for osteoarthritis treatments. |
| Market Trend | Increased joint disorders and an aging population are compelling a growing demand for viscosupplementation. |
| Market Restraint | High treatment costs hamper the market expansion for viscosupplementation. |
Orthobiologics Market:
| Attributes | Orthobiologics Market |
|---|---|
| Value-based CAGR (2024 to 2034) | 3.0% |
| Growth Factor | The orthobiologics market is expanding due to the rising need for regenerative medicines. |
| Market Trend | Orthobiologics is changing due to advancements in stem cell therapy. |
| Market Restraint | Broad adoption of orthobiologics is hampered by limited reimbursement choices. |
Cartilage Repair Market:
| Attributes | Cartilage Repair Market |
|---|---|
| Value-based CAGR (2024 to 2034) | 13.9% |
| Growth Factor | Personalized solutions offered by 3D bioprinting revolutionize the cartilage repair market. |
| Market Trend | Global demand for cartilage repair is stimulated by the increasing prevalence of osteoarthritis. |
| Market Restraint | The broad adoption of cartilage restoration techniques is hampered by limited insurance coverage. |
The segmented market analysis of viscosupplementation is included in the following subsection. Based on comprehensive studies, the three injection viscosupplementation sector is leading the product category, and the ambulatory surgical center segment is commanding the end user category.
The three-injection viscosupplementation category is estimated to dominate the market in 2024, accounting for 48.4%. Given the following, it makes sense:
| Leading Segment | Three Injection Viscosupplementation |
|---|---|
| Segment Share | 48.4% |
The ambulatory surgical centers sector is expected to rule the viscosupplementation treatment market in 2024 with a 31.9% market share. Several aspects of the choice include:
| Leading Segment | Ambulatory Surgical Centers |
|---|---|
| Segment Share | 31.9% |
The following tables show the viscosupplementation market, focusing on the largest economies in North America, Europe, and Asia Pacific. A thorough analysis reveals that China has significant prospects due to its resilient viscosupplementation producers.
With great potential, the China viscosupplementation market is expected to continue to thrive at a steady CAGR of 9.0% through 2034. This expansion is supported by:
| Country | China |
|---|---|
| CAGR | 9.0% |
The Japan viscosupplementation treatment market is expected to evolve at a CAGR of 8.5% through 2034. The following is an explanation of this:
| Country | Japan |
|---|---|
| CAGR | 8.5% |
Brazil viscosupplementation market is expected to flourish at a 6.2% CAGR through 2034. This expansion is maintained by:
| Country | Brazil |
|---|---|
| CAGR | 6.2% |
The Germany viscosupplementation treatment market is anticipated to evolve at a constant 4.0% CAGR through 2034. This is clarified by:
| Country | Germany |
|---|---|
| CAGR | 4.0% |
The United States viscosupplementation market is expected to foster a 3.9% CAGR through 2034. An outline of this is given below:
| Country | United States |
|---|---|
| CAGR | 3.9% |
Prominent viscosupplementation vendors are vital in determining the competitive environment, and each one advances the expansion and improvement of the sector. Sanofi S.A. is a notable viscosupplementation provider, offering its knowledge and inventiveness.
Zimmer While Bioventus LLC and Anika Therapeutics Inc. offer distinctive advantages and contributions to the viscosupplementation market, Biomet Holdings Inc. is another important participant recognized for its noteworthy achievements. The pharmaceutical experience of Fidia Farmaceutici S.p.A. and Ferring B.V. adds to the market's varied portfolio.
Notable viscosupplementation producers promoting improvements in medical science include Seikagaku Corporation and Chugai Pharmaceutical Co., Ltd. OrthogenRx Inc., which contributes unique advantages to the competitive environment. At the same time, Mylan N.V. expands the market through its presence.
The major viscosupplementation manufacturers collectively influence the market dynamics, propelling innovations, dependability, and creativity in the industry. Continuous improvement is expected as they negotiate the market's potential and difficulties, guaranteeing the evolution of viscosupplementation for better patient care.
Noteworthy Advancements
| Company | Details |
|---|---|
| Juniper Biologics | A license agreement was made in April 2022 between Juniper Biologics and Kolon Life Sciences to develop and commercialize TissueGene-C low dose (TG-C LD). This experimental non-surgical treatment is injected once into the joint to treat osteoarthritis in the knee. |
| OrthogenRx, Inc. | OrthogenRx, Inc., a pioneer in viscosupplementation therapies for knee osteoarthritis, was purchased by the medical technology company Avanos Medical in December 2021. Avanos uses the FDA-approved GenVisc850 and TriVisc. |
| Ono Pharmaceutical Co., Ltd. | Ono Pharmaceutical Co., Ltd. and Seikagaku Corporation introduced JOYCLU 30mg intra-articular injection in May 2021. Seikagaku was granted manufacturing and marketing approval in Japan in March 2021 for this joint function enhancement agent. |
| Sanofi S.A. | Sanofi S.A.'s 'Synvisc-one' viscosupplement combines two cross-linked polymers with hyaluronic acid formulations. Due to its synthetic makeup, it can operate as a gel and a fluid. The high molecular weight is said to increase the therapeutic efficacy over the long run. |
| Anika Therapeutics, Inc. | At the International Cartilage Regeneration and Joint Preservation Society (ICRS), Anika Therapeutics, Inc. revealed Hyalofast, a hyaluronic acid-based scaffold for cartilage regeneration. |
| DUROLANE | FDA-approved DUROLANE, a Bioventus single-injection H.A. medication, is intended to relieve knee osteoarthritis pain. |
The viscosupplementation treatment market is to receive a valuation of US$ 2,167.3 million in 2024.
The demand for viscosupplementation is estimated to attain US$ 3,777.4 million by 2034.
Through 2034, the viscosupplementation industry is anticipated to develop at a 5.7% CAGR.
From 2019 to 2023, the sales of viscosupplementation registered a 4.4% CAGR.
The three injection viscosupplementation sector is set to achieve a market share of 48.4%.
A 31.9% market share is expected for the ambulatory surgical centers sector.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Product Life Cycle Analysis 3.5. Supply Chain Analysis 3.5.1. Supply Side Participants and their Roles 3.5.1.1. Producers 3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers) 3.5.1.3. Wholesalers and Distributors 3.5.2. Value Added and Value Created at Node in the Supply Chain 3.5.3. List of Raw Material Suppliers 3.5.4. List of Existing and Potential Buyer’s 3.6. Investment Feasibility Matrix 3.7. Value Chain Analysis 3.7.1. Profit Margin Analysis 3.7.2. Wholesalers and Distributors 3.7.3. Retailers 3.8. PESTLE and Porter’s Analysis 3.9. Regulatory Landscape 3.9.1. By Key Regions 3.9.2. By Key Countries 3.10. Regional Parent Market Outlook 3.11. Production and Consumption Statistics 3.12. Import and Export Statistics 4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034 4.1. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Analysis, 2019 to 2023 4.2. Current and Future Market Size Value (US$ Million) & Volume (Unit Pack) Projections, 2024 to 2034 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Product 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Analysis By Product, 2019 to 2023 5.3. Current and Future Market Size Value (US$ Million) & Volume (Unit Pack) Analysis and Forecast By Product, 2024 to 2034 5.3.1. Single Injection Viscosupplementation 5.3.2. Three Injection Viscosupplementation 5.3.3. Five Injection Viscosupplementation 5.4. Y-o-Y Growth Trend Analysis By Product, 2019 to 2023 5.5. Absolute $ Opportunity Analysis By Product, 2024 to 2034 6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Application 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Analysis By Application, 2019 to 2023 6.3. Current and Future Market Size Value (US$ Million) & Volume (Unit Pack) Analysis and Forecast By Application, 2024 to 2034 6.3.1. Knee Osteoarthritis 6.3.2. Hip Osteoarthritis 6.3.3. Shoulder Osteoarthritis 6.3.4. Others 6.4. Y-o-Y Growth Trend Analysis By Application, 2019 to 2023 6.5. Absolute $ Opportunity Analysis By Application, 2024 to 2034 7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By End User 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Analysis By End User, 2019 to 2023 7.3. Current and Future Market Size Value (US$ Million) & Volume (Unit Pack) Analysis and Forecast By End User, 2024 to 2034 7.3.1. Hospitals 7.3.2. Ambulatory Surgical Centers 7.3.3. Orthopedic Clinics 7.3.4. Retail Pharmacies 7.3.5. Online Sales 7.4. Y-o-Y Growth Trend Analysis By End User, 2019 to 2023 7.5. Absolute $ Opportunity Analysis By End User, 2024 to 2034 8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region 8.1. Introduction 8.2. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Analysis By Region, 2019 to 2023 8.3. Current Market Size Value (US$ Million) & Volume (Unit Pack) Analysis and Forecast By Region, 2024 to 2034 8.3.1. North America 8.3.2. Latin America 8.3.3. Western Europe 8.3.4. Eastern Europe 8.3.5. South Asia and Pacific 8.3.6. East Asia 8.3.7. Middle East and Africa 8.4. Market Attractiveness Analysis By Region 9. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 9.1. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Trend Analysis By Market Taxonomy, 2019 to 2023 9.2. Market Size Value (US$ Million) & Volume (Unit Pack) Forecast By Market Taxonomy, 2024 to 2034 9.2.1. By Country 9.2.1.1. USA 9.2.1.2. Canada 9.2.2. By Product 9.2.3. By Application 9.2.4. By End User 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Product 9.3.3. By Application 9.3.4. By End User 9.4. Key Takeaways 10. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 10.1. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Trend Analysis By Market Taxonomy, 2019 to 2023 10.2. Market Size Value (US$ Million) & Volume (Unit Pack) Forecast By Market Taxonomy, 2024 to 2034 10.2.1. By Country 10.2.1.1. Brazil 10.2.1.2. Mexico 10.2.1.3. Rest of Latin America 10.2.2. By Product 10.2.3. By Application 10.2.4. By End User 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Product 10.3.3. By Application 10.3.4. By End User 10.4. Key Takeaways 11. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 11.1. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Trend Analysis By Market Taxonomy, 2019 to 2023 11.2. Market Size Value (US$ Million) & Volume (Unit Pack) Forecast By Market Taxonomy, 2024 to 2034 11.2.1. By Country 11.2.1.1. Germany 11.2.1.2. UK 11.2.1.3. France 11.2.1.4. Spain 11.2.1.5. Italy 11.2.1.6. Rest of Western Europe 11.2.2. By Product 11.2.3. By Application 11.2.4. By End User 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Product 11.3.3. By Application 11.3.4. By End User 11.4. Key Takeaways 12. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 12.1. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Trend Analysis By Market Taxonomy, 2019 to 2023 12.2. Market Size Value (US$ Million) & Volume (Unit Pack) Forecast By Market Taxonomy, 2024 to 2034 12.2.1. By Country 12.2.1.1. Poland 12.2.1.2. Russia 12.2.1.3. Czech Republic 12.2.1.4. Romania 12.2.1.5. Rest of Eastern Europe 12.2.2. By Product 12.2.3. By Application 12.2.4. By End User 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Product 12.3.3. By Application 12.3.4. By End User 12.4. Key Takeaways 13. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 13.1. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Trend Analysis By Market Taxonomy, 2019 to 2023 13.2. Market Size Value (US$ Million) & Volume (Unit Pack) Forecast By Market Taxonomy, 2024 to 2034 13.2.1. By Country 13.2.1.1. India 13.2.1.2. Bangladesh 13.2.1.3. Australia 13.2.1.4. New Zealand 13.2.1.5. Rest of South Asia and Pacific 13.2.2. By Product 13.2.3. By Application 13.2.4. By End User 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Product 13.3.3. By Application 13.3.4. By End User 13.4. Key Takeaways 14. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 14.1. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Trend Analysis By Market Taxonomy, 2019 to 2023 14.2. Market Size Value (US$ Million) & Volume (Unit Pack) Forecast By Market Taxonomy, 2024 to 2034 14.2.1. By Country 14.2.1.1. China 14.2.1.2. Japan 14.2.1.3. South Korea 14.2.2. By Product 14.2.3. By Application 14.2.4. By End User 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Product 14.3.3. By Application 14.3.4. By End User 14.4. Key Takeaways 15. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 15.1. Historical Market Size Value (US$ Million) & Volume (Unit Pack) Trend Analysis By Market Taxonomy, 2019 to 2023 15.2. Market Size Value (US$ Million) & Volume (Unit Pack) Forecast By Market Taxonomy, 2024 to 2034 15.2.1. By Country 15.2.1.1. GCC Countries 15.2.1.2. South Africa 15.2.1.3. Israel 15.2.1.4. Rest of MEA 15.2.2. By Product 15.2.3. By Application 15.2.4. By End User 15.3. Market Attractiveness Analysis 15.3.1. By Country 15.3.2. By Product 15.3.3. By Application 15.3.4. By End User 15.4. Key Takeaways 16. Key Countries Market Analysis 16.1. USA 16.1.1. Pricing Analysis 16.1.2. Market Share Analysis, 2023 16.1.2.1. By Product 16.1.2.2. By Application 16.1.2.3. By End User 16.2. Canada 16.2.1. Pricing Analysis 16.2.2. Market Share Analysis, 2023 16.2.2.1. By Product 16.2.2.2. By Application 16.2.2.3. By End User 16.3. Brazil 16.3.1. Pricing Analysis 16.3.2. Market Share Analysis, 2023 16.3.2.1. By Product 16.3.2.2. By Application 16.3.2.3. By End User 16.4. Mexico 16.4.1. Pricing Analysis 16.4.2. Market Share Analysis, 2023 16.4.2.1. By Product 16.4.2.2. By Application 16.4.2.3. By End User 16.5. Germany 16.5.1. Pricing Analysis 16.5.2. Market Share Analysis, 2023 16.5.2.1. By Product 16.5.2.2. By Application 16.5.2.3. By End User 16.6. UK 16.6.1. Pricing Analysis 16.6.2. Market Share Analysis, 2023 16.6.2.1. By Product 16.6.2.2. By Application 16.6.2.3. By End User 16.7. France 16.7.1. Pricing Analysis 16.7.2. Market Share Analysis, 2023 16.7.2.1. By Product 16.7.2.2. By Application 16.7.2.3. By End User 16.8. Spain 16.8.1. Pricing Analysis 16.8.2. Market Share Analysis, 2023 16.8.2.1. By Product 16.8.2.2. By Application 16.8.2.3. By End User 16.9. Italy 16.9.1. Pricing Analysis 16.9.2. Market Share Analysis, 2023 16.9.2.1. By Product 16.9.2.2. By Application 16.9.2.3. By End User 16.10. Poland 16.10.1. Pricing Analysis 16.10.2. Market Share Analysis, 2023 16.10.2.1. By Product 16.10.2.2. By Application 16.10.2.3. By End User 16.11. Russia 16.11.1. Pricing Analysis 16.11.2. Market Share Analysis, 2023 16.11.2.1. By Product 16.11.2.2. By Application 16.11.2.3. By End User 16.12. Czech Republic 16.12.1. Pricing Analysis 16.12.2. Market Share Analysis, 2023 16.12.2.1. By Product 16.12.2.2. By Application 16.12.2.3. By End User 16.13. Romania 16.13.1. Pricing Analysis 16.13.2. Market Share Analysis, 2023 16.13.2.1. By Product 16.13.2.2. By Application 16.13.2.3. By End User 16.14. India 16.14.1. Pricing Analysis 16.14.2. Market Share Analysis, 2023 16.14.2.1. By Product 16.14.2.2. By Application 16.14.2.3. By End User 16.15. Bangladesh 16.15.1. Pricing Analysis 16.15.2. Market Share Analysis, 2023 16.15.2.1. By Product 16.15.2.2. By Application 16.15.2.3. By End User 16.16. Australia 16.16.1. Pricing Analysis 16.16.2. Market Share Analysis, 2023 16.16.2.1. By Product 16.16.2.2. By Application 16.16.2.3. By End User 16.17. New Zealand 16.17.1. Pricing Analysis 16.17.2. Market Share Analysis, 2023 16.17.2.1. By Product 16.17.2.2. By Application 16.17.2.3. By End User 16.18. China 16.18.1. Pricing Analysis 16.18.2. Market Share Analysis, 2023 16.18.2.1. By Product 16.18.2.2. By Application 16.18.2.3. By End User 16.19. Japan 16.19.1. Pricing Analysis 16.19.2. Market Share Analysis, 2023 16.19.2.1. By Product 16.19.2.2. By Application 16.19.2.3. By End User 16.20. South Korea 16.20.1. Pricing Analysis 16.20.2. Market Share Analysis, 2023 16.20.2.1. By Product 16.20.2.2. By Application 16.20.2.3. By End User 16.21. GCC Countries 16.21.1. Pricing Analysis 16.21.2. Market Share Analysis, 2023 16.21.2.1. By Product 16.21.2.2. By Application 16.21.2.3. By End User 16.22. South Africa 16.22.1. Pricing Analysis 16.22.2. Market Share Analysis, 2023 16.22.2.1. By Product 16.22.2.2. By Application 16.22.2.3. By End User 16.23. Israel 16.23.1. Pricing Analysis 16.23.2. Market Share Analysis, 2023 16.23.2.1. By Product 16.23.2.2. By Application 16.23.2.3. By End User 17. Market Structure Analysis 17.1. Competition Dashboard 17.2. Competition Benchmarking 17.3. Market Share Analysis of Top Players 17.3.1. By Regional 17.3.2. By Product 17.3.3. By Application 17.3.4. By End User 18. Competition Analysis 18.1. Competition Deep Dive 18.1.1. Sanofi S.A. 18.1.1.1. Overview 18.1.1.2. Product Portfolio 18.1.1.3. Profitability by Market Segments 18.1.1.4. Sales Footprint 18.1.1.5. Strategy Overview 18.1.1.5.1. Marketing Strategy 18.1.1.5.2. Product Strategy 18.1.1.5.3. Channel Strategy 18.1.2. Zimmer Biomet Holdings Inc. 18.1.2.1. Overview 18.1.2.2. Product Portfolio 18.1.2.3. Profitability by Market Segments 18.1.2.4. Sales Footprint 18.1.2.5. Strategy Overview 18.1.2.5.1. Marketing Strategy 18.1.2.5.2. Product Strategy 18.1.2.5.3. Channel Strategy 18.1.3. Bioventus LLC 18.1.3.1. Overview 18.1.3.2. Product Portfolio 18.1.3.3. Profitability by Market Segments 18.1.3.4. Sales Footprint 18.1.3.5. Strategy Overview 18.1.3.5.1. Marketing Strategy 18.1.3.5.2. Product Strategy 18.1.3.5.3. Channel Strategy 18.1.4. Anika Therapeutics Inc. 18.1.4.1. Overview 18.1.4.2. Product Portfolio 18.1.4.3. Profitability by Market Segments 18.1.4.4. Sales Footprint 18.1.4.5. Strategy Overview 18.1.4.5.1. Marketing Strategy 18.1.4.5.2. Product Strategy 18.1.4.5.3. Channel Strategy 18.1.5. Fidia Farmaceutici S.p.A. 18.1.5.1. Overview 18.1.5.2. Product Portfolio 18.1.5.3. Profitability by Market Segments 18.1.5.4. Sales Footprint 18.1.5.5. Strategy Overview 18.1.5.5.1. Marketing Strategy 18.1.5.5.2. Product Strategy 18.1.5.5.3. Channel Strategy 18.1.6. Ferring B.V. 18.1.6.1. Overview 18.1.6.2. Product Portfolio 18.1.6.3. Profitability by Market Segments 18.1.6.4. Sales Footprint 18.1.6.5. Strategy Overview 18.1.6.5.1. Marketing Strategy 18.1.6.5.2. Product Strategy 18.1.6.5.3. Channel Strategy 18.1.7. Seikagaku Corporation 18.1.7.1. Overview 18.1.7.2. Product Portfolio 18.1.7.3. Profitability by Market Segments 18.1.7.4. Sales Footprint 18.1.7.5. Strategy Overview 18.1.7.5.1. Marketing Strategy 18.1.7.5.2. Product Strategy 18.1.7.5.3. Channel Strategy 18.1.8. Chugai Pharmaceutical Co., Ltd. 18.1.8.1. Overview 18.1.8.2. Product Portfolio 18.1.8.3. Profitability by Market Segments 18.1.8.4. Sales Footprint 18.1.8.5. Strategy Overview 18.1.8.5.1. Marketing Strategy 18.1.8.5.2. Product Strategy 18.1.8.5.3. Channel Strategy 18.1.9. OrthogenRx Inc. 18.1.9.1. Overview 18.1.9.2. Product Portfolio 18.1.9.3. Profitability by Market Segments 18.1.9.4. Sales Footprint 18.1.9.5. Strategy Overview 18.1.9.5.1. Marketing Strategy 18.1.9.5.2. Product Strategy 18.1.9.5.3. Channel Strategy 18.1.10. Mylan N.V. 18.1.10.1. Overview 18.1.10.2. Product Portfolio 18.1.10.3. Profitability by Market Segments 18.1.10.4. Sales Footprint 18.1.10.5. Strategy Overview 18.1.10.5.1. Marketing Strategy 18.1.10.5.2. Product Strategy 18.1.10.5.3. Channel Strategy 19. Assumptions & Acronyms Used 20. Research Methodology
Explore Healthcare Insights
View Reports
Viscosupplementation Market
